290 related articles for article (PubMed ID: 30520183)
1. Antiparasitic Activity of Auranofin against Pathogenic Naegleria fowleri.
Peroutka-Bigus N; Bellaire BH
J Eukaryot Microbiol; 2019 Jul; 66(4):684-688. PubMed ID: 30520183
[TBL] [Abstract][Full Text] [Related]
2. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Jung SY; Lee YJ; Song KJ; Kwon D; Kim K; Park S; Im KI; Shin HJ
Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
[TBL] [Abstract][Full Text] [Related]
3. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
Goswick SM; Brenner GM
J Parasitol; 2003 Aug; 89(4):837-42. PubMed ID: 14533700
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Lee YJ; Sohn HJ; Song KJ; Kwon D; Kwon MH; Im KI; Shin HJ
Int J Antimicrob Agents; 2008 Nov; 32(5):411-7. PubMed ID: 18762406
[TBL] [Abstract][Full Text] [Related]
5. Primary amoebic meningoencephalitis in an infant.
Mittal N; Mahajan L; Hussain Z; Gupta P; Khurana S
Indian J Med Microbiol; 2019; 37(1):120-122. PubMed ID: 31424023
[TBL] [Abstract][Full Text] [Related]
6. Primary amoebic meningoencephalitis: amoebicidal effects of clinically approved drugs against Naegleria fowleri.
Baig AM; Kulsoom H; Khan NA
J Med Microbiol; 2014 May; 63(Pt 5):760-762. PubMed ID: 24493160
[No Abstract] [Full Text] [Related]
7. The anti-amoebic potential of carboxamide derivatives containing sulfonyl or sulfamoyl moieties against brain-eating Naegleria fowleri.
Akbar N; Siddiqui R; El-Gamal MI; Zaraei SO; Alawfi BS; Khan NA
Parasitol Res; 2023 Nov; 122(11):2539-2548. PubMed ID: 37665414
[TBL] [Abstract][Full Text] [Related]
8. Fatal case of Naegleria fowleri meningo-encephalitis in an infant: case report.
Hebbar S; Bairy I; Bhaskaranand N; Upadhyaya S; Sarma MS; Shetty AK
Ann Trop Paediatr; 2005 Sep; 25(3):223-6. PubMed ID: 16156990
[TBL] [Abstract][Full Text] [Related]
9. The 4-Aminomethylphenoxy-Benzoxaborole AN3057 as a Potential Treatment Option for Primary Amoebic Meningoencephalitis.
Ženíšková K; Mach J; Arbon D; Štursa J; Werner L; Zoltner M; Sutak R
Antimicrob Agents Chemother; 2023 Feb; 67(2):e0150622. PubMed ID: 36688657
[TBL] [Abstract][Full Text] [Related]
10. Naegleria fowleri: pathogenesis, diagnosis, and treatment options.
Grace E; Asbill S; Virga K
Antimicrob Agents Chemother; 2015 Nov; 59(11):6677-81. PubMed ID: 26259797
[TBL] [Abstract][Full Text] [Related]
11. Fatal primary meningoencephalitis caused by Naegleria fowleri.
Shariq A; Afridi FI; Farooqi BJ; Ahmed S; Hussain A
J Coll Physicians Surg Pak; 2014 Jul; 24(7):523-5. PubMed ID: 25052979
[TBL] [Abstract][Full Text] [Related]
12. Activity of Auranofin against Multiple Genotypes of
Escrig JI; Hahn HJ; Debnath A
ACS Chem Neurosci; 2020 Aug; 11(16):2464-2471. PubMed ID: 32392039
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis.
Linam WM; Ahmed M; Cope JR; Chu C; Visvesvara GS; da Silva AJ; Qvarnstrom Y; Green J
Pediatrics; 2015 Mar; 135(3):e744-8. PubMed ID: 25667249
[TBL] [Abstract][Full Text] [Related]
14. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
[TBL] [Abstract][Full Text] [Related]
15. Oleic Acid Coated Silver Nanoparticles Showed Better
Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
[No Abstract] [Full Text] [Related]
16. CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).
Debnath A; Calvet CM; Jennings G; Zhou W; Aksenov A; Luth MR; Abagyan R; Nes WD; McKerrow JH; Podust LM
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006104. PubMed ID: 29284029
[TBL] [Abstract][Full Text] [Related]
17. Novel chemotherapeutic strategies in the management of primary amoebic meningoencephalitis due to Naegleria fowleri.
Baig AM; Khan NA
CNS Neurosci Ther; 2014 Mar; 20(3):289-90. PubMed ID: 24456292
[No Abstract] [Full Text] [Related]
18. Diagnosis of the primary amoebic meningoencephalitis due to Naegleria fowleri.
Hara T; Fukuma T
Parasitol Int; 2005 Dec; 54(4):219-21. PubMed ID: 16002330
[TBL] [Abstract][Full Text] [Related]
19. Flucofuron as a Promising Therapeutic Agent against Brain-Eating Amoeba.
Chao-Pellicer J; Arberas-Jiménez I; Sifaoui I; Piñero JE; Lorenzo-Morales J
ACS Infect Dis; 2024 Jun; 10(6):2063-2073. PubMed ID: 38757533
[TBL] [Abstract][Full Text] [Related]
20. Identification of Naegleria fowleri proteins linked to primary amoebic meningoencephalitis.
Jamerson M; Schmoyer JA; Park J; Marciano-Cabral F; Cabral GA
Microbiology (Reading); 2017 Mar; 163(3):322-332. PubMed ID: 28086072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
